Company profilePharmaceutical#930 of 1,318 in Pakistan✓ No DRAP alerts

S.J & G. Fazal Ellahie (Pvt) Ltd.

Pharmaceutical company · 5 brands · 8 molecules

Ranked #29 of 74 companies in Pain Management

5 registered products 8 pharmaceutical brands 8 distinct molecules 0 DRAP alerts

Company overview

5
registered products
8
pharmaceutical brands
8
distinct molecules
7
therapeutic classes
0
DRAP alerts

S.J & G. Fazal Ellahie (Pvt) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 5 product registrations across 8 distinct molecules. Its portfolio is concentrated in Pain Management and Neuro. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by S.J

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Top molecules by brand count

Escitalopram ...... 20 Mg1 brand
Escitalopram ...... 10 Mg1 brand
Escitalopram ...... 5 Mg1 brand
Tizanidine1 brand
Lincomycin1 brand
Mebeverine1 brand

Therapeutic classes

Pain Management · 3Neuro · 1Antidepressants · 1Muscle Relaxant · 1Macrolides, Lincosamides And Streptogramins · 1Anti-Infectives · 1Antiinflammatory And Antirheumatic Products · 1

Conditions treated

Muscle Relaxant/Spasm · 2Anxiety/Depression/Insomnia · 1General Infections · 1Pain Killers · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official3 products · Rs 635.45 – Rs 953.19
DVAGO2 products · Rs 68.4 – Rs 544.54
Servaid6 products · Rs 112 – Rs 356.1
Median across source: Rs 306.47

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

FYNK PHARMACEUTICALS5 shared molecules
BIO LABS (PVT) LTD.5 shared molecules
PharmEvo Private Limited4 shared molecules
IRZA PHARMA (PVT) LTD.4 shared molecules
SHROOQ PHARMACEUTICALS4 shared molecules
AGP (PRIVATE) LTD.4 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NAWAN LABORATORIES (PVT) LTD. holds 38 molecules not in this portfolio
ArtemetherAtorvastatinAzithromycinCalciumCefaclor BpCefixime
FYNK PHARMACEUTICALS holds 2 molecules not in this portfolio
BisoprololItopride
BIO LABS (PVT) LTD. holds 139 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate

Get the full profile for S.J

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.